Activation of p53 Gene Expression and Synergistic Antiproliferative Effects of 5-Fluorouracil and B-escin on MCF7 Cells
DOI: 10.4103/jmss.JMSS_44_18
Abstract
One of the most common malignancies in women is breast cancer. B-escin has pharmacological anticancer effects. 5-fluorouracil (5-FU) has antimetabolite and antiproliferative properties. The purpose of this study was to investigate the combined effects of 5-FU and B-escin on apoptosis, colony formation, Bcl-2 signaling protein, and p53 gene expression in MCF7 breast cancer cell line. The cytotoxic effects, the number of colonies, apoptosis, p53 gene expression, and Bcl-2 signaling protein of the combined 5-FU and B-escin on MCF7 cells were determined using 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide, clonogenic assay, flow cytometry, real-time quantitative polymerase chain reaction, and western blotting methods, respectively. Half-maximal inhibitory concentration values of B-escin and 5-FU were 80 Micro g/ml and 2 Micro M, respectively. The combination of 5-FU and B-escin on MCF7 cell viability showed a combination index equal to 0.5. The expression of p53 and apoptosis increased in the combination of 5-FU and B-escin on MCF7 cells compared to that of control group (P < 0.05). In addition, the number of colonies and Bcl-2 signaling protein in combination of 5-FU and B-escin decreased with respect to untreated control cells or single treatment of 5-FU and B-escin. The combination of 5-FU and B-escin not only has synergistic effects by increasing cell apoptosis and p53 gene expression but also decreases Bcl-2 signaling protein in MCF7 cell lines.
Keywords
Full Text:
PDFReferences
Vahid F, Hatami M, Sadeghi M, Ameri F, Faghfoori Z, Davoodi SH, et al. The association between the index of nutritional quality (INQ) and breast cancer and the evaluation of nutrient intake of breast cancer patients: A case-control study. Nutrition 2018;45:11-6.
Mohebian MR, Marateb HR, Mansourian M, Mananas MA, Mokarian F. A hybrid computer-aided-diagnosis system for prediction of breast cancer recurrence (HPBCR) using optimized ensemble learning. Comput Struct Biotechnol J 2017;15:75-85.
Patlolla JM, Qian L, Biddick L, Zhang Y, Desai D, Amin S, et al. B-escin inhibits NNK-induced lung adenocarcinoma and ALDH1A1 and rhoA/rock expression in A/J mice and growth of H460 human lung cancer cells. Cancer Prev Res (Phila) 2013;6:1140-9.
Xiao GM, Wei J. Effects of beta-aescin on the expression of nuclear factor-kappaB and tumor necrosis factor-alpha after traumatic brain injury in rats. J Zhejiang Univ Sci B 2005;6:28-32.
Rimmon A, Vexler A, Berkovich L, Earon G, Ron I, Lev-Ari S, et al. Escin chemosensitizes human pancreatic cancer cells and inhibits the nuclear factor-kappaB signaling pathway. Biochem Res Int 2013;2013:251752.
Ming ZJ, Hu Y, Qiu YH, Cao L, Zhang XG. Synergistic effects of beta-aescin and 5-fluorouracil in human hepatocellular carcinoma SMMC-7721 cells. Phytomedicine 2010;17:575-80.
Piao S, Kang M, Lee YJ, Choi WS, Chun YS, Kwak C, et al. Cytotoxic effects of escin on human castration-resistant prostate cancer cells through the induction of apoptosis and G2/M cell cycle arrest. Urology 2014;84:982.e1-7.
Niu YP, Wu LM, Jiang YL, Wang WX, Li LD. Beta-escin, a natural triterpenoid saponin from chinese horse chestnut seeds, depresses HL-60 human leukaemia cell proliferation and induces apoptosis. J Pharm Pharmacol 2008;60:1213-20.
Patlolla JM, Raju J, Swamy MV, Rao CV. Beta-escin inhibits colonic aberrant crypt foci formation in rats and regulates the cell cycle growth by inducing p21(waf1/cip1) in colon cancer cells. Mol Cancer Ther 2006;5:1459-66.
Sirtori CR. Aescin: Pharmacology, pharmacokinetics and therapeutic profile. Pharmacol Res 2001;44:183-93.
Palesh O, Scheiber C, Kesler S, Mustian K, Koopman C, Schapira L, et al. Management of side effects during and post-treatment in breast cancer survivors. Breast J 2018;24:167-75.
Gnanapradeepan K, Basu S, Barnoud T, Budina-Kolomets A, Kung CP, Murphy ME, et al. The p53 tumor suppressor in the control of metabolism and ferroptosis. Front Endocrinol (Lausanne) 2018;9:124.
Aubrey BJ, Kelly GL, Janic A, Herold MJ, Strasser A. How does p53 induce apoptosis and how does this relate to p53-mediated tumour suppression? Cell Death Differ 2018;25:104-13.
Marquez-Jurado S, Diaz-Colunga J, das Neves RP, Martinez-Lorente A, Almazan F, Guantes R, et al. Mitochondrial levels determine variability in cell death by modulating apoptotic gene expression. Nat Commun 2018;9:389.
Opferman JT, Kothari A. Anti-apoptotic BCL-2 family members in development. Cell Death Differ 2018;25:37-45.
Sun W, Sanderson PE, Zheng W. Drug combination therapy increases successful drug repositioning. Drug Discov Today 2016;21:1189-95.
Wang YW, Wang SJ, Zhou YN, Pan SH, Sun B. Escin augments the efficacy of gemcitabine through down-regulation of nuclear factor-kB and nuclear factor-kB-regulated gene products in pancreatic cancer both in vitro and in vivo. J Cancer Res Clin Oncol 2012;138:785-97.
Heidarian E, Keloushadi M, Ghatreh-Samani K, Jafari-Dehkordi E. Gallic acid inhibits invasion and reduces IL-6 gene expression, PSTAT3, PERK1/2, and pAKT cellular signaling proteins in human prostate cancer DU-145 cells. Int J Cancer Manag 2017;10:e9163. doi: 10.5812/ijcm.9163.
Wang J, Liu W, Zhao Q, Qi Q, Lu N, Yang Y, et al. Synergistic effect of 5-fluorouracil with gambogic acid on BGC-823 human gastric carcinoma. Toxicology 2009;256:135-40.
Busch CJ, Kroger MS, Jensen J, Kriegs M, Gatzemeier F, Petersen C, et al. G2-checkpoint targeting and radiosensitization of HPV/p16-positive HNSCC cells through the inhibition of chk1 and wee1. Radiother Oncol 2017;122:260-6.
Mojzisova G, Kello M, Pilatova M, Tomeckova V, Vaskova J, Vasko L, et al. Antiproliferative effect of B-escin-an in vitro study. Acta Biochim Pol 2016;63:79-87.
Kumar MR, Aithal K, Rao BN, Udupa N, Rao BS. Cytotoxic, genotoxic and oxidative stress induced by 1,4-naphthoquinone in B16F1 melanoma tumor cells. Toxicol In Vitro 2009;23:242-50.
Pauzi AZ, Yeap SK, Abu N, Lim KL, Omar AR, Aziz SA, et al. Combination of cisplatin and bromelain exerts synergistic cytotoxic effects against breast cancer cell line MDA-MB-231 in vitro. Chin Med 2016;11:46.
Eskandari E, Heidarian E, Amini SA, Saffari-Chaleshtori J. Evaluating the effects of ellagic acid on pSTAT3, pAKT, and pERK1/2 signaling pathways in prostate cancer PC3 cells. J Cancer Res Ther 2016;12:1266-71.
Bradford MM. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 1976;72:248-54.
Korkina LG. Phenylpropanoids as naturally occurring antioxidants: From plant defense to human health. Cell Mol Biol (Noisy-le-grand) 2007;53:15-25.
Chinembiri TN, du Plessis LH, Gerber M, Hamman JH, du Plessis J. Review of natural compounds for potential skin cancer treatment. Molecules 2014;19:11679-721.
Yasueda A, Urushima H, Ito T. Efficacy and interaction of antioxidant supplements as adjuvant therapy in cancer treatment: A systematic review. Integr Cancer Ther 2016;15:17-39.
Varshney A, Bala J, Santosh B, Bhaskar A, Kumar S, Yadava PK, et al. Identification of an RNA aptamer binding hTERT-derived peptide and inhibiting telomerase activity in MCF7 cells. Mol Cell Biochem 2017;427:157-67.
Hu Y, Shen Y, Ji B, Yin S, Ren X, Chen T, et al. Liver-specific gene therapy of hepatocellular carcinoma by targeting human telomerase reverse transcriptase with pegylated immuno-lipopolyplexes. Eur J Pharm Biopharm 2011;78:320-5.
Eitsuka T, Nakagawa K, Kato S, Ito J, Otoki Y, Takasu S, et al. Modulation of telomerase activity in cancer cells by dietary compounds: A review. Int J Mol Sci 2018;19:E478.
He B, Wei W, Liu J, Xu Y, Zhao G. Synergistic anticancer effect of curcumin and chemotherapy regimen FP in human gastric cancer MGC-803 cells. Oncol Lett 2017;14:3387-94.
Lopes-Costa E, Abreu M, Gargiulo D, Rocha E, Ramos AA. Anticancer effects of seaweed compounds fucoxanthin and phloroglucinol, alone and in combination with 5-fluorouracil in colon cells. J Toxicol Environ Health A 2017;80:776-87.
Mitra S, Dash R. Natural products for the management and prevention of breast cancer. Evid Based Complement Alternat Med 2018;2018:8324696.
Hwang JT, Ha J, Park OJ. Combination of 5-fluorouracil and genistein induces apoptosis synergistically in chemo-resistant cancer cells through the modulation of AMPK and COX-2 signaling pathways. Biochem Biophys Res Commun 2005;332:433-40.
Hu XY, Liang JY, Guo XJ, Liu L, Guo YB. 5-fluorouracil combined with apigenin enhances anticancer activity through mitochondrial membrane potential -mediated apoptosis in hepatocellular carcinoma. Clin Exp Pharmacol Physiol 2015;42:146-53.
Gowda Saralamma VV, Lee HJ, Raha S, Lee WS, Kim EH, Lee SJ, et al. Inhibition of IAPs and activation of p53 leads to caspase-dependent apoptosis in gastric cancer cells treated with scutellarein. Oncotarget 2018;9:5993-6006.
Osaki M, Tatebe S, Goto A, Hayashi H, Oshimura M, Ito H, et al. 5-fluorouracil (5-FU) induced apoptosis in gastric cancer cell lines: Role of the p53 gene. Apoptosis 1997;2:221-6.
Xavier CP, Lima CF, Rohde M, Pereira-Wilson C. Quercetin enhances 5-fluorouracil-induced apoptosis in MSI colorectal cancer cells through p53 modulation. Cancer Chemother Pharmacol 2011;68:1449-57.
Guney G, Kutlu HM, Iscan A. The apoptotic effects of escin in the H-ras transformed 5RP7 cell line. Phytother Res 2013;27:900-5.
Shen DY, Kang JH, Song W, Zhang WQ, Li WG, Zhao Y, et al. Apoptosis of human cholangiocarcinoma cell lines induced by B-escin through mitochondrial caspase-dependent pathway. Phytother Res 2011;25:1519-26.
Refbacks
- There are currently no refbacks.
https://e-rasaneh.ir/Certificate/22728
ISSN : 2228-7477